# US 2019/0170763 A1 · Use of mild electrophiles to reduce artifacts in analyzing glycans released from glycoproteins or glycopeptides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0170763 A1
- Document ID: US20190170763A1
- Status: Published application
- Kind: A1
- Application number: 16/322,900
- Filed: 2017-08-16
- Published: 2019-06-06
- Earliest claimed: 2016-08-17
- Assignees: ProZyme, Inc.
- Applicants: ProZyme, Inc.
- Inventors: Michael J. KIMZEY
- Web page: https://patentgrep.com/patent/US20190170763A1

## CPC

- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- C09B 19/00: Oxazine dyes
- C09B 57/02: Coumarine dyes
- C09B 57/08: Naphthalimide dyes; Phthalimide dyes
- C12P 19/04: Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
- G01N 33/5308: {for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites}
- G01N 33/582: {with fluorescent label}
- G01N 33/6854: {Immunoglobulins}
- G01N 2400/10: Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C09B: ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES {, e.g. PIGMENTS}; MORDANTS; LAKES (fermentation or enzyme using processes to synthesise a desired chemical compound C12P)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

The presence of mild electrophiles, such as aldehydes, during the denaturation of glycoproteins or glycopeptides and subsequent enzymatic deglycosylation reduces artifacts in subsequent analyses of the glycans released from the glycoproteins or glycopeptides.

## Claims

### Claim 1

An in vitro method of labeling glycosylamines released from a glycoprotein or glycopeptide of interest, said method comprising:
(a) forming a mixture of said glycoprotein or glycopeptide and a mild electrophile in a solution,
(b) incubating said mixture in said solution at a first temperature and for a time sufficient to denature said glycoprotein or glycopeptide,
(c) reducing said temperature of said mixture in said solution to a second temperature, which second temperature is suitable for enzymatic deglycosylation of said glycoprotein or glycopeptide,
(d) contacting said glycoprotein or glycopeptide at said second temperature with at least one deglycosylation enzyme which releases glycans from a glycoprotein or glycopeptide as glycosylamines, thereby releasing glycans from said glycoprotein or glycopeptide as glycosylamines, and
(e) contacting said released glycosylamines with an amine-reactive dye under conditions allowing said amine-reactive dye to label said released glycosylamines,
thereby labeling said released glycosylamines.

### Claim 2 (depends on 1)

The method of claim 1, wherein said first temperature is 90° C. or higher.

### Claim 3 (depends on 1)

The method of claim 1, wherein said solution further comprises a detergent.

### Claim 4 (depends on 1)

The method of claim 1, wherein said at least one deglycosylation enzyme which releases glycans from said glycoprotein or glycopeptide as glycosylamines is PNGase F.

### Claim 5 (depends on 1)

The method of claim 1, wherein said mild electrophile is DL-glyceraldehyde, glyceraldehyde dimer, glycoaldehyde dimer, erythrose, pyruvaldehyde, 2-ethylbutyraldehyde, 2-methylbutyraldehyde, 2-methylvaleraldehyde, 4-methyl-4-nitrovaleraldehyde, acetaldehyde, butyraldehyde, isobutyraldehyde, propionaldehyde, or valeraldehyde.

### Claim 6 (depends on 5)

The method of claim 5, wherein said mild electrophile is DL-glyceraldehyde, glyceraldehyde dimer, or glycoaldehyde dimer.

### Claim 7 (depends on 5)

The method of claim 5, wherein said mild electrophile is DL-glyceraldehyde.

### Claim 8 (depends on 5)

The method of claim 5, wherein said mild electrophile is glyceraldehyde dimer.

### Claim 9 (depends on 5)

The method of claim 5, wherein said mild electrophile is glycoaldehyde dimer.

### Claim 10 (depends on 1)

The method of claim 1, wherein said glycoprotein of interest is an antibody.

### Claim 11 (depends on 1)

The method of claim 1, wherein said contacting of released glycosylamines with said amine-reactive dye in step (e) is within 30 minutes of release from said glycoprotein or glycopeptide.

### Claim 12 (depends on 1)

The method of claim 1, wherein said contacting of released glycosylamines with said amine-reactive dye in step (e) is within 15 minutes of release from said glycoprotein or glycopeptide.

### Claim 13 (depends on 1)

The method of claim 1, wherein said contacting of released glycosylamines with said amine-reactive dye in step (e) is within 1 minute of release of said glycosylamines from said glycoprotein or glycopeptide.

### Claim 14 (depends on 1)

The method of claim 1, wherein said amine-reactive dye is selected from the group consisting of (2-(diethylamino)ethyl 4-[(2,5-dioxopyrrolidin-1-yl)oxycarbonylamino]benzoate) (InstantPC™), 8-[(2,5-dioxopyrrolidin-1-yl)oxycarbonylamino]naphthalene-1,3,5-trisulfonic acid (“Amine-reactive ANTS™”), 4-[(2,5-dioxopyrrolidin-1-yl)oxycarbonylamino]benzoic acid (“InstantAA™”), (7-[(2,5-dioxopyrrolidin-1-yl)oxycarbonylamino]naphthalene-1,3,6-trisulfonic acid) (“InstantQ™”), and RAPIFLUOR-MS®.

### Claim 15 (depends on 1)

The method of claim 1, wherein said released glycosylamines are at or at about room temperature when contacted with said amine-reactive dye.

### Claim 16 (depends on 1)

The method of claim 1, further comprising either:
step (f), providing said labeled glycosylamines to an analytical means, or
step (f′) subjecting said labeled glycosylamines to a solid phase extraction means that reduces the amount of mild electrophile present, to obtain labeled glycosylamines with a reduced amount of said mild electrophile present, and step (f″) providing said labeled glycosylamines with said reduced amount of said mild electrophile present to an analytical means.

### Claim 17 (depends on 16)

The method of claim 16, wherein said solid phase extraction means is a solid phase cartridge.

### Claim 18 (depends on 16)

The method of claim 16, wherein said analytical means is selected from the group consisting of high-pressure liquid chromatography, capillary electrophoresis, fluorescence analysis, mass spectrometry, and a combination of any of these.

### Claim 19 (depends on 1)

The method of claim 1, wherein said glycoprotein of interest is in a biological sample.

### Claim 20 (depends on 19)

The method of claim 19, wherein said biological sample is selected from the group consisting of: a cell culture supernatant, a membrane protein preparation, milk, a tissue sample, cerebrospinal fluid, plasma, serum, urine, a respiratory secretion, bile synovial fluid, pleural fluid, lymph, tears, saliva, and a stool sample.

### Claim 21 (depends on 20)

The method of claim 20, wherein said biological sample is milk.

### Claim 22

A composition, comprising: (i) a detergent, (ii) a mild electrophile, (iii) at least one deglycosylation enzyme which releases glycans from said glycoprotein as glycosylamines, (iv) a partially or fully deglycosylated protein or peptide from which glycans have been removed by said deglycosylation enzyme, and (v) glycosylamines released from said partially or fully deglycosylated protein by said enzyme.

### Claim 23 (depends on 22)

The composition of claim 22, further wherein said glycoprotein is an antibody.

### Claim 24 (depends on 22)

The composition of claim 22, further wherein said deglycosylation enzyme is PNG F.

### Claim 25 (depends on 22)

The composition of claim 22, further wherein said mild electrophile is DL-glyceraldehyde, glyceraldehyde dimer, glycoaldehyde dimer, erythrose, pyruvaldehyde, 2-ethylbutyraldehyde, 2-methylbutyraldehyde, 2-methylvaleraldehyde, 4-methyl-4-nitrovaleraldehyde, acetaldehyde, butyraldehyde, isobutyraldehyde, propionaldehyde, or valeraldehyde.

### Claim 26 (depends on 22)

The method of claim 22, wherein said mild electrophile is DL-glyceraldehyde, glyceraldehyde dimer, or glycoaldehyde dimer.

### Claim 27 (depends on 22)

The method of claim 22, wherein said mild electrophile is DL-glyceraldehyde.

### Claim 28

An in vitro method of reducing artifacts in analyzing glycans released from a glycoprotein or glycopeptide and labeled by reductive amination, said method comprising the following steps in the following order:
(a) forming a solution comprising said glycoprotein or glycopeptide, and a mild electrophile, under conditions allowing said mild electrophile to block any nucleophilic components present in said solution or on said glycoprotein or glycopeptide,
(b) heating said solution to a first temperature, and for a time, sufficient to denature said glycoprotein or glycopeptide,
(c) reducing said temperature of said solution to a second, cooler temperature,
(d) releasing glycans from said glycoprotein or glycopeptide,
(e) labeling said glycans released from said glycoprotein or glycopeptide by reductive amination, and
(f) analyzing said glycans labeled by said reductive amination,
whereby said blocking of said nucleophilic components present in said solution or on said glycoprotein or glycopeptide prior to said denaturation and reductive amination reduces artifacts in said analysis of said released glycans.

### Claim 29 (depends on 28)

The method of claim 28, wherein said mild electrophile is DL-glyceraldehyde, glyceraldehyde dimer, glycoaldehyde dimer, erythrose, pyruvaldehyde, 2-ethylbutyraldehyde, 2-methylbutyraldehyde, 2-methylvaleraldehyde, 4-methyl-4-nitrovaleraldehyde, acetaldehyde, butyraldehyde, isobutyraldehyde, propionaldehyde, or valeraldehyde.

### Claim 30 (depends on 29)

The method of claim 29, wherein said mild electrophile is DL-glyceraldehyde, glyceraldehyde dimer, or glycoaldehyde dimer.

### Claim 31 (depends on 29)

The method of claim 29, wherein said mild electrophile is DL-glyceraldehyde.

### Claim 32 (depends on 29)

The method of claim 29, wherein said mild electrophile is glyceraldehyde dimer.

### Claim 33 (depends on 29)

The method of claim 29, wherein said mild electrophile is glycoaldehyde dimer.

### Claim 34 (depends on 28)

The method of claim 28, wherein said glycoprotein is an antibody.

### Claim 35 (depends on 28)

The method of claim 28, wherein said glycoprotein of interest is in a biological sample.

### Claim 36 (depends on 35)

The method of claim 35, wherein said biological sample is selected from the group consisting of: a cell culture supernatant, a membrane protein preparation, milk, a tissue sample, cerebrospinal fluid, plasma, serum, urine, a respiratory secretion, bile synovial fluid, pleural fluid, lymph, tears, saliva, and a stool sample.

### Claim 37 (depends on 36)

The method of claim 36, wherein said biological sample is milk.

### Claim 38 (depends on 28)

The method of claim 28, wherein said solution further comprises a detergent.

### Claim 39 (depends on 28)

The method of claim 28, wherein said analysis is selected from the group consisting of high-pressure liquid chromatography, capillary electrophoresis, fluorescence analysis, mass spectrometry, and a combination of any of these.

### Claim 40

A method of reducing artifacts in analyzing glycans released from a glycoprotein or glycopeptide without labeling, said method comprising the following steps in the following order:
(a) forming a solution comprising said glycoprotein or glycopeptide, and a mild electrophile, under conditions allowing said mild electrophile to block any nucleophilic components present in said solution or on said glycoprotein or glycopeptide,
(b) heating said solution to a first temperature, and for a time, sufficient to denature said glycoprotein or glycopeptide,
(c) reducing said temperature of said solution to a second, cooler temperature,
(d) releasing glycans from said glycoprotein or glycopeptide, and
(e) analyzing said glycans labeled by said reductive amination,
whereby said blocking of said nucleophilic components present in said solution or on said glycoprotein or glycopeptide prior to said denaturation reduces artifacts in said analysis of said released glycans.

### Claim 41 (depends on 40)

The method of claim 40, wherein said analysis is by mass spectrometry, High-performance Anion Exchange Chromatography coupled with Pulsed Amperometric Detection (“HPAE-PAD”), Charged Aerosol Detection (“CAD”), Evaporative Light Scattering Detection (“ELSD”), or a combination of any of these.

### Claim 42

A kit for labeling glycosylamines released from a glycoprotein or glycopeptide, said kit comprising,
(a) a mild electrophile,
(b) an amine-reactive dye, an agent for performing reductive amination, or both an amine-reactive dye and an agent for performing reductive amination, and
(c) instructions on denaturing said glycoprotein or glycopeptide in the presence of said mild electrophile.

### Claim 43 (depends on 42)

The kit of claim 42, wherein said agent for performing reductive amination is anthranilic acid (“2-AA”) or 2-aminobenzamide (“2-AB”).

### Claim 44 (depends on 42)

The kit of claim 42, further comprising a deglycosylation enzyme.

### Claim 45 (depends on 44)

The kit of claim 44, further wherein said deglycosylation enzyme is PNGase F.

### Claim 46 (depends on 42)

The kit of claim 42, wherein said mild electrophile is DL-glyceraldehyde, glyceraldehyde dimer, glycoaldehyde dimer, erythrose, pyruvaldehyde, 2-ethylbutyraldehyde, 2-methylbutyraldehyde, 2-methylvaleraldehyde, 4-methyl-4-nitrovaleraldehyde, acetaldehyde, butyraldehyde, isobutyraldehyde, propionaldehyde, or valeraldehyde.

### Claim 47 (depends on 42)

The kit of claim 42, wherein said mild electrophile is DL-glyceraldehyde, glyceraldehyde dimer, or glycoaldehyde dimer.

### Claim 48 (depends on 47)

The kit of claim 47, wherein said mild electrophile is DL-glyceraldehyde.

### Claim 49 (depends on 42)

The kit of claim 42, wherein said amine-reactive dye is selected from the group consisting of (2-(diethylamino)ethyl 4-[(2,5-dioxopyrrolidin-1-yl)oxycarbonylamino]benzoate) (InstantPC™), 8-[(2,5-dioxopyrrolidin-1-yl)oxycarbonylamino]naphthalene-1,3,5-trisulfonic acid (“InstantANTS™”), 4-[(2,5-dioxopyrrolidin-1-yl)oxycarbonylamino]benzoic acid (“InstantAA™”), (7-[(2,5-dioxopyrrolidin-1-yl)oxycarbonylamino]naphthalene-1,3,6-trisulfonic acid) (“7-ANTS”), and RAPIFLUOR-MS®.
